AFC-HD AMS Life Science Co., Ltd. (JP:2927) has released an update.
AFC-HD AMS Life Science Co., Ltd. sees robust financial growth with an 18% increase in net sales and a 17.3% rise in operating profit compared to the previous year. The company reported a solid 12.9% growth in profit attributable to owners and a slightly increased return on equity at 8.9%. Despite these gains, the capital adequacy ratio has experienced a slight dip from 31.9% to 29.7%.
For further insights into JP:2927 stock, check out TipRanks’ Stock Analysis page.